Arkolith/Insider Trading/FREQ/Form 4

Loose Christopher R.

Chief Scientific OfficerFrequency Therapeutics, Inc. (FREQ) · full profile →Form 4 · filed Jul 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 20, 2023Sell(S)1K$0.64$871192K
Jul 19, 2023Sell(S)1K$0.65$868193K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-23-021133) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML